Maxime Le Merdy
Maxime Le Merdy publishes mostly in Pharmaceutical Science, Oncology and Pediatrics, Perinatology and Child Health, on topics such as Drug Solubulity and Delivery Systems, Advanced Drug Delivery Systems and Pharmacogenetics and Drug Metabolism.
- World rank
- #4,236,882 of 7,710,434 ranked researchers
- Rank in United States
- #1,142,246 of 1,627,098
- Works
- 23
- Citations
- 260
- Citations per work
- 11.3
What does Maxime Le Merdy research?
Maxime Le Merdy's work is mostly in Pharmacology, Toxicology and Pharmaceutics (27%), Medicine (23%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1042.2%
- Life Sciences834.4%
- Health Sciences523.4%
- Medicine523.4%
- 1Pharmaceutical Science20% of their works
- 2Oncology8% of their works
- 3Pediatrics, Perinatology and Child Health8% of their works
- 4Pharmacology8% of their works
- 5Molecular Biology8% of their works
- 6Pharmacology6% of their works
Research topics
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical studies and practices
- Protein purification and stability
- Protein Interaction Studies and Fluorescence Analysis
Which keywords describe Maxime Le Merdy's research?
The keywords of their largest research topics: Chitosan, Cyclodextrins, Nanoparticles, Solid Dispersions, Antibiotic Pharmacokinetics, ATP-dependent Transporters, Critically Ill Patients and Cytochrome P450.
- Serum Albumin
- Protein Aggregation
- Pediatric Pharmacokinetics
- Pharmacogenetics
- Cytochrome P450
- Antibiotic Pharmacokinetics
- Solid Dispersions
- Cyclodextrins
- Chitosan
- Nanoparticles
- ATP-dependent Transporters
- Critically Ill Patients
- Multidrug Resistance
- Off-Label Drug Use
- Biopharmaceuticals
- Protein Binding
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Chitosan61 topic
- Cyclodextrins61 topic
- Nanoparticles61 topic
- Solid Dispersions61 topic
- ATP-dependent Transporters41 topic
- Antibiotic Pharmacokinetics41 topic
- Critically Ill Patients41 topic
- Cytochrome P45041 topic
- Multidrug Resistance41 topic
- Pharmacogenetics41 topic
- Off-Label Drug Use31 topic
- Pediatric Pharmacokinetics31 topic
- Biopharmaceuticals21 topic
- Protein Aggregation21 topic
- Protein Binding21 topic
- Serum Albumin21 topic
Where does Maxime Le Merdy work?
Maxime Le Merdy's main affiliation in the publication record is Simulations Plus (United States), United States.
How many publications and citations does Maxime Le Merdy have?
OpenAlex counts 23 works and 260 citations for Maxime Le Merdy, an h-index of 10, ranking #4,236,882 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Maxime Le Merdy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.